# Cevimeline Hydrochloride

NDC: 33342-216
Generic name: Cevimeline Hydrochloride
Labeler / Manufacturer: Macleods Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20241020

FDA application: ANDA206808

## Active ingredients

- CEVIMELINE HYDROCHLORIDE: 30 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"33342-216"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=33342-216
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=990887c1-11ce-4a73-83b4-0ffc5a900c85